Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Sci Rep ; 13(1): 7147, 2023 05 02.
Article in English | MEDLINE | ID: mdl-37130900

ABSTRACT

Developing new capabilities to predict the risk of intracranial aneurysm rupture and to improve treatment outcomes in the follow-up of endovascular repair is of tremendous medical and societal interest, both to support decision-making and assessment of treatment options by medical doctors, and to improve the life quality and expectancy of patients. This study aims at identifying and characterizing novel flow-deviator stent devices through a high-fidelity computational framework that combines state-of-the-art numerical methods to accurately describe the mechanical exchanges between the blood flow, the aneurysm, and the flow-deviator and deep reinforcement learning algorithms to identify a new stent concepts enabling patient-specific treatment via accurate adjustment of the functional parameters in the implanted state.


Subject(s)
Aneurysm, Ruptured , Endovascular Procedures , Intracranial Aneurysm , Humans , Intracranial Aneurysm/surgery , Stents , Treatment Outcome , Hemodynamics , Endovascular Procedures/methods
2.
Eur J Surg Oncol ; 43(11): 2184-2192, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28801061

ABSTRACT

BACKGROUND: The role of lymph node dissection (LND) in renal cell carcinoma (RCC) is still under debate. We aimed to assess the utilization rates of LND over time in Europe. METHODS: A multi-institutional database of 13,581 RCC patients who underwent radical nephrectomy (RN) or nephron sparing surgery (NSS) between 1988 and 2014 was created within an European consortium. We analysed temporal trends in the frequency of LND by using Joinpoint regression. Logistic regression models were used to identify predictors of LND. RESULTS: Overall, 5114 patients (42.7%) underwent LND. Lymph node invasion was recorded in 566 cases (11% of LND patients) which represents 4.7% of the whole study cohort. A gradual decline in the use of LND started in the 1990s. After 2008 LND decreased significantly by 21.5% per year (95%CI -33.3 to -7.5, p < 0.01) until 2011 and stabilized thereafter (Annual Percentage Change 4.9%, 95%CI -3.4 to 13.8, p = 0.2). At multivariable analyses, patient age (OR 0.98, p < 0.0001), type of surgery (RN vs. NSS: OR 5.46, p < 0.0001), surgical approach (open vs. minimally invasive: OR 1.75, p < 0.0001), T stage (T2 vs. T1: OR 1.57; T3-4 vs. T1: OR 1.44, p < 0.0001), clinical tumour size (OR 1.14, p < 0.0001), and year of surgery (OR 0.95, p < 0.0001) were associated with higher probability of LND at nephrectomy. CONCLUSIONS: A trend towards lower LND was observed over time for RCC patients who underwent RN or NSS. LND is more frequently performed in younger patients, locally advanced diseases and in case of open surgery.


Subject(s)
Carcinoma, Renal Cell/pathology , Carcinoma, Renal Cell/surgery , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Lymph Node Excision/trends , Aged , Europe , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Nephrectomy , Retrospective Studies
3.
Eur J Surg Oncol ; 43(8): 1581-1588, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28330822

ABSTRACT

BACKGROUND: Radical prostatectomy (RP) is the gold standard for clinically localized prostate cancer (PCa) patients with life expectancy (LE) of at least 10 years. We examined long-term survival of men aged 80 years or older treated with RP and we attempted to identify criteria based on age and comorbidities that could predict survival of at least 10 years after RP, to identify those that might be considered for RP. PATIENTS AND METHODS: In Surveillance Epidemiology and End Results (SEER)-Medicare-linked database, we identified 234 octo- and nonagenarians with clinical T1, T2 or T3 PCa treated with RP between 1991 and 2009. Kaplan-Meier analyses examined 10-year survival patterns. Multivariable Cox regression analyses focused on the combined effect of age and/or Charlson Comorbidity Index (CCI) after adjusting for different confounders. RESULTS: The 10-year overall survival (OS) and cancer specific mortality (CSM) rates in the overall population were 51 and 9.9%. In individuals aged 80-81 years old, the 10-year OS was 62.4 vs. 39.6% in older patients (p = 0.001). Moreover, combination of age 80-81 with CCI = 0 yielded 10-year OS of 67.9 vs. 28.5% in older and sicker patients (p < 0.001). Age 80-81, absence of comorbidities and the combination of age 80-81 with CCI = 0, represented independent predictors of lower overall mortality (all p ≤ 0.01). CONCLUSIONS: Two out of three individuals selected for RP aged 80-81 years and without comorbidities, fulfill the criterion of LE of 10 years or more. Therefore, elderly PCa individuals can be suitable for surgical management, if appropriately selected, based on LE criterion.


Subject(s)
Prostatectomy , Prostatic Neoplasms/mortality , Prostatic Neoplasms/surgery , Aged, 80 and over , Comorbidity , Humans , Male , SEER Program , Survival Rate
4.
Eur J Surg Oncol ; 43(4): 815-822, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27692535

ABSTRACT

BACKGROUND: Local tumour ablation (LTA) may yield better perioperative outcomes than partial nephrectomy (PN), however the impact of each treatment on perioperative mortality and health care expenditures is unknown. The aim of the study was to compare mortality, morbidity and health care expenditures between LTA and PN. PATIENTS AND METHODS: A population-based assessment of 2471 patients with cT1a kidney cancer treated with either LTA or PN, between 2000 and 2009, in the SEER-Medicare database was performed. After propensity score matching, 30-day mortality, overall and specific complication rates, length of stay, readmission rates and health care expenditures according to LTA or PN were estimated. Multivariable logistic and linear models addressed the effect of each specific LTA approach on overall complication rates, length of stay, readmission rates and health care expenditures. RESULTS: The 30-day mortality was <2% after either LTA or PN (OR 2.27, p = 0.2). The overall complication rate was 21% after LTA and 40% after PN (OR 0.38, p < 0.001). Blood transfusions, infection/sepsis, wound infections, respiratory complications, gastrointestinal complications, acute kidney injury, and accidental puncture or laceration/foreign body left during procedure rates resulted lower after LTA relative to PN (all p < 0.05). Similarly, length of stay and health care expenditures resulted lower after LTA relative to PN (all p < 0.05). Conversely, readmission rate was not significantly different in LTA relative to PN (p = 0.1). CONCLUSIONS: Despite similar perioperative mortality, LTA is associated with lower complications rate, shorter length of stay and lower health care expenditure relative to PN.


Subject(s)
Carcinoma, Renal Cell/surgery , Catheter Ablation/methods , Health Expenditures , Kidney Neoplasms/surgery , Nephrectomy/methods , Postoperative Complications/epidemiology , Acute Kidney Injury/economics , Acute Kidney Injury/epidemiology , Aged , Aged, 80 and over , Blood Transfusion/economics , Blood Transfusion/statistics & numerical data , Carcinoma, Renal Cell/economics , Catheter Ablation/adverse effects , Catheter Ablation/economics , Female , Humans , Iatrogenic Disease/economics , Iatrogenic Disease/epidemiology , Kidney Neoplasms/economics , Laparoscopy , Laparotomy , Linear Models , Logistic Models , Male , Medicare , Mortality , Multivariate Analysis , Nephrectomy/adverse effects , Nephrectomy/economics , Postoperative Complications/economics , Propensity Score , Respiratory Tract Diseases/economics , Respiratory Tract Diseases/epidemiology , Retrospective Studies , SEER Program , Sepsis/economics , Sepsis/epidemiology , Surgical Wound Infection/economics , Surgical Wound Infection/epidemiology , Treatment Outcome , United States/epidemiology
5.
Eur J Surg Oncol ; 41(11): 1547-53, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26117216

ABSTRACT

PURPOSE: Contemporary adherence of the indication to European Association of Urology (EAU) guideline recommendation for pelvic lymph node dissection (PLND) at either open (ORP) or robot-assisted radical prostatectomy (RARP) at a high-volume center is unknown. To assess guideline recommended and observed PLND rates in a high-volume center cohort. METHODS: We relied on the Martini-Clinic database and focused on patients treated with either ORP or RARP, between 2010 and 2013. Actual performed PLND was compared to European Association of Urology (EAU) guideline recommendation defined by nomogram predicted risk of lymph node invasion >5%. Categorical and multivariable logistic regression analyses targeted two endpoints: 1) probability of guideline recommended PLND and 2) probability of no PLND, when not recommended by EAU guideline. RESULTS: Within 7868 PCa patients, adherence to EAU PLND guideline recommendation was 97.1% at ORP and 96.8% at RARP (p = 0.7). When PLND was not recommended, it was more frequently performed at RARP (71.6%) than at ORP (66.2%) (p = 0.002). Gleason score, PSA and number of positive biopsy cores were independent predictors for both either PLND when recommended, or no PLND when not recommended (all p < 0.05). Clinical tumor stage, age and surgical approach were also independent predictors for no PLND when not recommended (all p < 0.05). CONCLUSIONS: Adherence of the indication to EAU guideline recommended PLND is high at this high-volume center. Neither ORP nor RARP represent a barrier for PLND, when recommended. However, a high number of patients underwent PLND despite absence of guideline recommendation. Possible staging advantages and PLND related complications needs to be individually considered, especially, when LNI risk is low.


Subject(s)
Conversion to Open Surgery/methods , Guideline Adherence , Hospitals, High-Volume/statistics & numerical data , Lymph Node Excision/methods , Prostatectomy/methods , Prostatic Neoplasms/surgery , Robotics , Adult , Aged , Aged, 80 and over , Europe , Humans , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphatic Metastasis , Male , Middle Aged , Pelvis , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/secondary , Retrospective Studies , Urology
6.
Eur J Surg Oncol ; 41(3): 353-60, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25477269

ABSTRACT

PURPOSE: To compare long-term cancer outcomes after radical cystectomy (RC) alone or RC with pelvic lymph node dissection (PLND) according to different age and comorbidities categories. METHODS: Using the SEER-Medicare dataset, 3314 patients diagnosed with urothelial carcinoma of the urinary bladder and treated with RC alone or RC with PLND were identified. After propensity score matching to reduce potential selection bias, all cause mortality (ACM)-free and cancer specific mortality (CSM)-free survival rates were estimated. Multivariable regression models (MVA) addressed the effect of PLND on ACM and CSM. Subgroups analyses according to age and comorbidities were performed. RESULTS: After matching, 688 and 688 patients treated with RC alone or RC with PLND remained. The 5-year ACM-free survival rate was 36 after RC alone and 45% after RC with PLND (p < 0001). In MVA, PLND exerted a protective effect on ACM (HR 0.77, p < 0.001). The 5-year CSM-free survival rate was 54 after RC alone and 65% after RC with PLND (p < 0.001). In MVA, PLND exerted a protective effect on CSM (HR 0.71, p < 0.001). Similar results were observed in younger (age ≤75) and healthier (CCI = 0) patients, where PLND exerted a protective effect on ACM (HR 0.64, p = 0.001) and CSM (HR 0.65, p = 0.01). Conversely, in older (age >75) and sicker (CCI ≥1) patients, PLND was not associated with ACM (HR 0.98, p = 0.8) or CSM (HR 1.01, p = 0.9). CONCLUSIONS: RC with PLND is associated with improved all cause and cancer specific survival in younger and healthier RC candidates but not in older and sicker patients.


Subject(s)
Carcinoma, Transitional Cell/surgery , Cystectomy/methods , Lymph Node Excision/methods , Lymph Nodes/pathology , Urinary Bladder Neoplasms/surgery , Urinary Bladder/pathology , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/pathology , Cohort Studies , Cystectomy/mortality , Databases, Factual , Disease-Free Survival , Female , Humans , Lymph Node Excision/mortality , Male , Neoplasm Invasiveness , Pelvis , Prognosis , SEER Program , Treatment Outcome , Urinary Bladder Neoplasms/pathology
7.
Eur J Surg Oncol ; 40(12): 1738-45, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25454826

ABSTRACT

INTRODUCTION: Existing radical cystectomy (RC) perioperative mortality estimates may underestimate the contemporary rates due to more advanced age, more baseline comorbidities and potentially broader inclusion criteria for RC, relative to past criteria. METHODS: Within the most recent Surveillance, Epidemiology, and End Results (SEER)-Medicare database we identified clinically non-metastatic, muscle-invasive (T2-T4a) urothelial carcinoma of the urinary bladder (UCUB) patients, who underwent RC between 1991 and 2009. Mortality at 30- and 90-day after RC was quantified. Multivariable logistic regression analyses tested predictors of 90-day mortality. RESULTS: Within 5207 assessable RC patients 30- and 90-day mortality rates were 5.2 and 10.6%, respectively. According to age 65-69, 70-79 and ≥ 80 years, 90-day mortality rates were 6.4, 10.1 and 14.8% (p < 0.001). Additionally, 90-day mortality rates increased with increasing Charlson Comorbidity Index (CCI, 0, 1, 2 and ≥ 3): 6.3, 10.3, 12.6 and 15.9% (p < 0.001). 90-day mortality rate in unmarried patients was 13.0 vs. 9.3% in married individuals (p < 0.001). In multivariable logistic regression analyses, advanced age, higher CCI, low socioeconomic status, unmarried status and non organ-confined stage were independent predictors of 90-day mortality (all p < 0.05). CONCLUSIONS: The contemporary SEER-Medicare derived 90-day mortality rates are substantially higher than previously reported estimates from centers of excellence, and even exceed previous SEER reports. More advanced age, higher CCI score, and other patient characteristics that distinguish the current population from others account for these differences.


Subject(s)
Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/surgery , Cystectomy , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/surgery , Age Factors , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/pathology , Cohort Studies , Comorbidity , Cystectomy/methods , Female , Humans , Logistic Models , Male , Marital Status , Medicare , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Risk Factors , SEER Program , Social Class , United States/epidemiology , Urinary Bladder Neoplasms/pathology
8.
J Psychopharmacol ; 21(1): 102-11, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16714326

ABSTRACT

Social anxiety disorder is associated with impairment in social and occupational functioning, significant personal distress and a possible economic burden, resulting in a reduction in quality of life. To understand better the efficacy of selective serotonin reuptake inhibitors in social anxiety disorder, randomized, double-blind, placebo-controlled trials were evaluated. Pubmed and PsychINFO electronic databases were searched for social anxiety disorder, social phobia, selective serotonin reuptake inhibitors, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine and sertraline. Fifteen published, randomized, double-blind, placebo-controlled trials of selective serotonin reuptake inhibitors in social anxiety disorder were identified. Design, subject number, drug and dose, trial length, rating instruments, and baseline and end point data were extracted and then verified independently by a second investigator. Effect sizes were calculated from mean changes in drug and placebo groups in the Liebowitz Social Anxiety Scale and the Sheehan Disability Scale, as well as from other scales where available. For the binary data of the Clinical Global Impression of Change scores, Theta log-odds ratios (the effect-size measure appropriate for binary data) were calculated from proportion changes. Effect sizes for the Liebowitz Social Anxiety Scale ranged from -0.029 to 1.214. Effect sizes for the Sheehan Disability Scale ranged from 0.203 to 0.480 for work, 0.237 to 0.786 for social function, and 0.118 to 0.445 for family function. The Theta log-odds ratios for Clinical Global Impression of Change scores ranged from 0.644 to 3.267. Consistent with previous studies, selective serotonin reuptake inhibitors appear more effective than placebo for social anxiety disorder, with improvement extending into social and occupational function.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety Disorders/drug therapy , Phobic Disorders/drug therapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Anxiety Disorders/psychology , Humans , Odds Ratio , Phobic Disorders/psychology , Psychiatric Status Rating Scales , Randomized Controlled Trials as Topic/methods , Social Behavior , Time Factors , Treatment Outcome
9.
Article in French | AIM (Africa) | ID: biblio-1264096

ABSTRACT

Un Systeme d'Apprentissage Multimedia Interactif (SAMI) d'Hematologie (Travaux pratiques virtuels) developpe par la Faculte des Sciences de la Sante (FSS) de Cotonou et le Departement Communication; Audiovisuel; Multimedia (DCAM) de Bordeaux 2 a ete evalue.Vingt etudiants; choisis au hasard dans un groupe de 33 de 2eme annee de medecine; ont effectue; de facon autonome; les travaux pratiques virtuels (TPV) pour les groupages dans les systemes ABO et Rh ; les 13 restant ont fait les TP classiques. L'evaluation a ete theorique et pratique et les resultats en sont les suivants :Au plan global; 95des apprenants ont realise une performance allant de 80 a 100- Les performances realisees par les etudiants pour la maitrise des materiels et reactifs necessaires varient de 82 a 95en situation virtuelle et de 100en situation reelle - 85des etudiants ont obtenu une performance de 80 a 100en situation virtuelle pour la maitrise des modes operatoires et 95ont depasse 80de performance en situation reelle - Quant a l'interpretation des resultats; les performances varient de 92 a 100en situation virtuelle et de 80 a 100en situation reelle dont 100de score realise par 65des etudiants. En plus de ces acquisitions rapidement transmises par le SAMI d'Hematologie a la majorite des etudiants; seulement 30de la quantite de reactifs habituellement prevue pour les travaux pratiques classiques ont ete consommes ; les 70restant etant consommes par les 13 etudiants restant. Dans leur evaluation des TPV; les etudiants insistent sur le renforcement des exercices de l'auto evaluation et la systematisation de l'utilisation du SAMI pour tous les travaux pratiques


Subject(s)
Humans , Learning Health System , Learning , Health Sciences , Video-Audio Media
10.
Anesthesiology ; 92(2): 465-72, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10691234

ABSTRACT

BACKGROUND: It has been reported that mu-opioid receptor activation leads to a sustained increase in glutamate synaptic effectiveness at the N-methyl-D-aspartate (NMDA) receptor level, a system associated with central hypersensitivity to pain. One hypothesis is that postoperative pain may result partly from the activation of NMDA pain facilitatory processes induced by opiate treatment per se. The authors tested here the effectiveness of the opiate analgesic fentanyl for eliciting a delayed enhancement in pain sensitivity. METHODS: The consequences of four bolus injections (every 15 min) of fentanyl (20-100 microg/kg per injection, subcutaneously) on immediate (for several hours) and long-term (for several days) sensitivity to nociceptive stimuli in the rat (paw-pressure vocalization test) were evaluated. The effects of the combination of the NMDA-receptor antagonist ketamine (10 mg/kg, subcutaneously) with fentanyl also were assessed. RESULTS: Fentanyl administration exhibited a biphasic time-dependent effect: first, an early response (for 2-5 h) associated with a marked increase in nociceptive threshold (analgesia), and second, a later response associated with sustained lowering of the nociceptive threshold (5 days for the longest effect) below the basal value (30% of decrease for the maximal effect) indicative of hyperalgesia. The higher the fentanyl dose used, the more pronounced was the fentanyl-induced hyperalgesia. Ketamine pretreatment, which had no analgesic effect on its own, enhanced the earlier response (analgesia) and prevented the development of long-lasting hyperalgesia. CONCLUSIONS: Fentanyl activates NMDA pain facilitatory processes, which oppose analgesia and lead to long-lasting enhancement in pain sensitivity.


Subject(s)
Analgesics, Opioid/toxicity , Fentanyl/toxicity , Hyperalgesia/chemically induced , Animals , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , Ketamine/pharmacology , Male , Nociceptors/drug effects , Pain Measurement/drug effects , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley
11.
Brain Res ; 847(1): 18-25, 1999 Nov 13.
Article in English | MEDLINE | ID: mdl-10564731

ABSTRACT

The acute interaction between opioid receptors and N-methyl-D-aspartate (NMDA) receptors on nociception was examined in rats using tail-flick and paw-pressure vocalisation tests. When injected at various times (1 to 6 h) after morphine (5 to 20 mg/kg, i.v.) or fentanyl (4x40 microgram/kg, i.v.), the opioid receptor antagonist naloxone (1 mg/kg, s.c.) not only abolished the opiate-induced increase in nociceptive threshold, but also reduced it below the basal value (hyperalgesia). The noncompetitive NMDA receptor antagonist MK-801 (0.15 or 0.30 mg/kg, s.c.) prevented the naloxone-precipitated hyperalgesia and enhanced the antinociceptive effects of morphine (7.5 mg/kg, i.v.) and fentanyl (4x40 microgram/kg, i.v.). These results indicate that the antinociceptive effects of morphine and fentanyl, two opiate analgesics widely used in humans in the management of pain, are blunted by concomitant NMDA-dependent opposing effects which are only revealed when the predominant antinociceptive effect is sharply blocked by naloxone. This study provides new rationale for beneficial adjunction of NMDA receptor antagonists with opiates for relieving pain by preventing pain facilitatory processes triggered by opiate treatment per se.


Subject(s)
Analgesics, Opioid/pharmacology , Receptors, N-Methyl-D-Aspartate/physiology , Receptors, Opioid/physiology , Animals , Dizocilpine Maleate/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Fentanyl/pharmacology , Male , Morphine/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Nociceptors/drug effects , Nociceptors/physiology , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
12.
Neuroscience ; 89(3): 631-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10199599

ABSTRACT

From a classical viewpoint, tolerance to analgesic effects of opiates refers to the decreased effectiveness of a given opiate following its repeated use. Despite much research, it has not been conclusively demonstrated in vivo that functional changes observed at the opioid receptor level in the responsiveness to opiates account for development of tolerance. An alternative hypothesis is that opioid receptors remain operative following repeated opiate administration but that opioid receptor activation rapidly induces a prolonged increase in pain sensitivity which opposes the predominant opiate analgesic effect following repeated opiate administration. We recently showed that a single heroin administration induces an enhanced pain sensitivity for several days, a phenomenon which is prevented by the non-competitive N-methyl-D aspartate receptor antagonist MK-801. Herein we report that repeated once-daily heroin injections induced a gradual lowering of the nociceptive threshold which progressively masked a sustained heroin analgesic functional effect. MK-801 prevented such opiate-induced allodynia and thereby prevented development of an apparent decrease in the effectiveness of heroin. These results indicate that intermittent heroin administration induced a persistent increase in the basal pain sensitivity which, if not taken into account gives the impression of less analgesia, i.e. apparent tolerance.


Subject(s)
Analgesics, Opioid/toxicity , Drug Tolerance/physiology , Heroin/toxicity , Hyperalgesia/chemically induced , Pain Threshold/drug effects , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/therapeutic use , Animals , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Administration Schedule , Excitatory Amino Acid Antagonists/pharmacology , Foot , Heroin/administration & dosage , Heroin/therapeutic use , Hyperalgesia/physiopathology , Injections, Subcutaneous , Male , Pressure , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Vocalization, Animal
13.
Eur J Neurosci ; 10(2): 782-5, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9749743

ABSTRACT

Acute dependence, defined as a precipitation of somatic signs by an antagonist, may occur after a single administration of an opiate drug. Because hyperalgesia is a consistent sign of the withdrawal syndrome, we tested the effectiveness of heroin, an opiate used by addicts, to induce pain facilitation even after a first exposure to the drug. In opiate-naive rats, subcutaneous injection of heroin induced analgesia followed by allodynia, a decrease in pain threshold. This latter phenomenon was observed in the absence of noxious stimuli and lasted several days. An N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 prevented such long-lasting allodynia. These results suggest that allodynia is an early sign reflecting neural plasticity associated with the development of dependence.


Subject(s)
Heroin/pharmacology , Narcotics/pharmacology , Pain/psychology , Animals , Dizocilpine Maleate/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Male , Pain Measurement/drug effects , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Vocalization, Animal/drug effects
14.
Neuroscience ; 84(2): 583-9, 1998 May.
Article in English | MEDLINE | ID: mdl-9539228

ABSTRACT

Mechanisms underlying the development of acute tolerance to the analgesic effect of opiates were investigated. In the rat tail-flick test, administration of naloxone (1 mg/kg, s.c.) 40 min after heroin (1 mg/kg, s.c.) was shown to induce hyperalgesia, indicative of a short-onset, opiate-activated pain facilitatory systems masking the opiate analgesia. Pretreatment with the N-methyl-D-aspartate receptor antagonist dizocilpine maleate blocked, in a dose-dependent manner, the naloxone-induced hyperalgesia and potentiated the heroin-induced analgesia. Using a schedule of two successive injections of 1 mg/kg heroin, acute tolerance was indicated by a marked reduction (-52%) in analgesia induced by the second dose. After pretreatment with dizocilpine maleate, the acute tolerance was abolished and the analgesic effects of both injections of heroin were strongly potentiated. These observations indicate that acute tolerance appears after the first exposure to opiates and stems from opiate activation of N-methyl-D-aspartate-dependent pain facilitatory systems.


Subject(s)
Dizocilpine Maleate/pharmacology , Drug Tolerance/physiology , Heroin/pharmacology , Hyperalgesia/physiopathology , Naloxone/pharmacology , Pain/physiopathology , Analgesics, Opioid/pharmacology , Analysis of Variance , Animals , Hyperalgesia/chemically induced , Male , Pain Measurement/methods , Rats , Rats, Sprague-Dawley , Reaction Time
15.
Adv Exp Med Biol ; 449: 287-95, 1998.
Article in English | MEDLINE | ID: mdl-10026816

ABSTRACT

Our recent studies have shown that regulation of uterine oxytocin (OT) binding involves at least two different mechanism: Estradiol (E2)-induced upregulation is accompanied by an increase in OT receptor (OTR) mRNA accumulation, implying that the E2 effect is mediated via increased OTR gene transcription and/or OTR mRNA stabilization. In contrast, P (P)-induced OTR down-regulation occurs via a novel non-genomic mechanism, involving a direct interaction of P with the OTR at the level of the cell membrane. We found that P specifically binds to the OTR and inhibits its ligand binding and signalling functions. Physiological levels of P repress in vitro the ligand binding capacity (Bmax) of the OTR by > 50%. When expressed in CHO cells, the OTR provides a high affinity (Kd: 20nM) membrane binding site for P. OT-induced inositol phosphate production and intracellular calcium mobilization is inhibited 85% and 90%, respectively, by P. These effects are specific as signalling and binding functions of the closely related V1a vasopressin receptor remain unaffected by P, and as other, related steroids are devoid of any effect on OTR binding or signalling functions. The present observation of a specific interaction of a steroid with a G-protein-linked receptor defines a new mechanism of non-genomic steroid action and uncovers a novel level of crosstalk between steroid and peptide hormone action.


Subject(s)
Gene Expression Regulation , Receptors, Oxytocin/physiology , Animals , CHO Cells , Cricetinae , Estradiol/physiology , Female , Humans , Inositol Phosphates/metabolism , Oxytocin/pharmacology , Oxytocin/physiology , Pregnancy , Progesterone/physiology , Receptors, Oxytocin/genetics , Signal Transduction , Transcription, Genetic , Transfection , Up-Regulation
16.
Endocrinology ; 136(12): 5350-6, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7588281

ABSTRACT

It is well established that uterine oxytocin receptors (OTRs) are strongly up-regulated immediately before parturition as well as in response to estrogen (E2) administration. Progesterone (P4), on the other hand, induces a rapid down-regulation. We recently cloned the rat OTR gene and characterized its expression in the rat uterus. In this study, we examined the regulation of OTR messenger RNA (mRNA) levels in rat uterus during pregnancy, the estrous cycle, and in response to gonadal steroid treatment. OTR mRNA levels increased more than 25-fold during gestation: 4.5-fold during the first 21 days and 6-fold within 24 h between day 21 and the onset of parturition. Uterine OTR mRNA levels fell rapidly by 85% within 24 h following parturition. By in situ hybridization, OTR mRNA was localized specifically to the longitudinal and circular layers of the myometrium but was not detected in the endometrium. During the estrous cycle, OTR mRNA levels increased 2-fold between metestrus and proestrus, whereas oxytocin (OT) binding rose more than 10-fold within this same interval. Treatment of ovariectomized rats with E2 lead to a significant increase in both OTR mRNA levels (4.4-fold) and OT binding (< 6-fold). Cotreatment with P4 strongly reduced OT binding by 75% (P < 0.01) but did not significantly affect the E2-induced rise in OTR mRNA (11% decrease, P > 0.1). Our data suggest that the increased expression of OT binding sites observed at the onset of labor and at proestrus is mediated, at least in part, by an E2-induced up-regulation of OTR gene expression. However, it also appears that OTR mRNA levels are not the sole determinants of uterine OT binding. Specifically, P4-mediated OTR down-regulation cannot be explained by an effect on OTR mRNA accumulation and may involve novel mechanisms acting at translational or posttranslational levels.


Subject(s)
Estrus/metabolism , Gene Expression Regulation/drug effects , Gonadal Steroid Hormones/pharmacology , Pregnancy, Animal/metabolism , Receptors, Oxytocin/genetics , Uterus/metabolism , Animals , Binding Sites , Estradiol/pharmacology , Female , Oxytocin/metabolism , Pregnancy , Progesterone/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley
17.
Brain Res ; 700(1-2): 173-81, 1995 Nov 27.
Article in English | MEDLINE | ID: mdl-8624708

ABSTRACT

Neuropeptide FF (NPFF) is a mammalian FMRFamide-like octapeptide with antiopioid properties that inhibits morphine-induced analgesia but also produces hyperalgesia. In the present study, a series of three experiments was carried out to investigate the interactions between opioid receptor stimulation and antiopioid systems. First, by using in vitro superfusion system with rat spinal cord slices, we showed that morphine stimulated NPFF release in a dose-dependent manner. The stimulating effect which was observed with morphine concentrations as low as 100 fM reached a maximum at 0.1 nM, then decreased and was ineffective at 10 microM. The morphine-induced release of NPFF was abolished by naloxone (1 microM) but unaltered by tetrodotoxin. Second, by an in vivo approach, we showed that a single heroin administration (2.5 mg/kg, s.c.) elicited in 30 min a drastic drop (38%) in spinal NPFF content. In a third experiment, we evaluated the capacity of naloxone in revealing an antiopioid component associated with opioid receptor stimulation. The administration of naloxone (1 mg/kg, s.c..) 25 min following that of heroin (2.5 mg/kg, s.c.) not only abolished the heroin-induced increase of tail-flick latency, but also lowered it under the basal value by 30%. These results indicate that opioid receptor stimulation activates both pain inhibitory and pain facilitatory systems in which NPFF may play a significant role and that opiate-induced analgesia is always partly masked.


Subject(s)
Morphine/pharmacology , Neuropeptides/metabolism , Oligopeptides/metabolism , Pain/physiopathology , Receptors, Opioid/drug effects , Spinal Cord/drug effects , Animals , Heroin/pharmacology , In Vitro Techniques , Male , Morphine/antagonists & inhibitors , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Rats , Rats, Sprague-Dawley , Reaction Time , Spinal Cord/metabolism , Tetrodotoxin/pharmacology
18.
Mol Cell Endocrinol ; 114(1-2): 69-76, 1995 Oct 30.
Article in English | MEDLINE | ID: mdl-8674853

ABSTRACT

We and others have previously identified functional estrogen (E) and retinoic acid (RA) response elements in the human and rat oxytocin (OT) gene promoters. Whereas there is no direct evidence for a significant role of E or RA in the regulation of rat hypothalamic OT gene expression, we have recently demonstrated that in vivo administration of E strongly stimulates uterine OT gene expression. Here, we show that in vivo administration of RA similarly induces a significant increase in uterine OT gene expression. Moreover, we report that the E and RA effects are reproducible in vitro. Using short-term uterine organ explant cultures derived from 18-day pregnant rats, we found that E (50 nM) and RA (0.4 nM) increased OT mRNA levels 5.2- and 3-fold, respectively, suggesting a direct action of these agents on uterine OT gene expression. Finally, we analyzed uterine E and RA receptor gene expression during pregnancy. Using semi-quantitative Northern blot analysis, we found that mRNAs encoding the E receptor, the RA receptor alpha and RA receptor beta are present in rat uterus and that their levels rise by 3.7-, 3.6- and 5.8-fold, respectively, between day 14 of gestation and term. Taken together, the data suggest that, at term, the rat uterus has an increased capacity to respond to E and RA, and that both agents may be involved in mediating the dramatic increase of OT mRNA accumulation observed in the uterus at term.


Subject(s)
Estradiol/pharmacology , Oxytocin/genetics , Tretinoin/pharmacology , Uterus/drug effects , Uterus/metabolism , Animals , Female , Gene Expression/drug effects , Humans , In Vitro Techniques , Lactation , Pregnancy , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Estrogen/genetics , Receptors, Retinoic Acid/genetics
19.
Adv Exp Med Biol ; 395: 395-404, 1995.
Article in English | MEDLINE | ID: mdl-8713994

ABSTRACT

By Northern blot analysis and in situ hybridization, we have determined that, at term, the rat uterine epithelium represents a major site of oxytocin (OT) gene expression. OT mRNA levels increase > 150-fold during pregnancy and, at term, exceed hypothalamic OT mRNA by a factor of 70. By cryoultramicroscopy, OT immunoreactivity was localized to transport vesicles in the apical compartment of uterine epithelial cells. Estrogens (E) act as a strong inducer of uterine OT gene expression in vivo, and this effect is potentiated 7-fold by concomitant progesterone (P) administration. We have also cloned the rat OT receptor (OTR) gene and developed a polymerase chain reaction (PCR)-based assay to measure OTR mRNA. Whereas OTR mRNA is strongly induced by E, P does not potentiate but slightly attenuates the E-induced rise. However, E-induced OT binding is completely reversed by concomitant P administration, suggesting an additional post-transcriptional effect of P. The mechanisms of E-induction of the uterine OT gene remain unclear, inasmuch as the OTR gene promoter does not contain a classical estrogen response element (ERE). Moreover, transfection analysis of a 3.1 kb OTR gene promoter fragment linked to a luciferase reporter gene indicates that promoter activity is induced 5-fold by calcium ionophore A23187 but not by E.


Subject(s)
Oxytocin/genetics , Receptors, Oxytocin/genetics , Steroids/metabolism , Animals , Base Sequence , DNA, Complementary/genetics , Estrogens/pharmacology , Female , Gene Expression Regulation/drug effects , Humans , Molecular Sequence Data , Pregnancy , Progesterone/pharmacology , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Uterus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...